G05 (ADENOSINE TRIPHOSPHATE, IGNATIA AMARA, KALI PHOSPHORICUM, NATRUM MURIATICUM, NUX VOMICA, SULPHUR)
**Product type:** Human Otc Drug
**Active ingredient:** ADENOSINE TRIPHOSPHATE; DIBASIC POTASSIUM PHOSPHATE; SODIUM CHLORIDE; STRYCHNOS IGNATII SEED; STRYCHNOS NUX-VOMICA SEED; SULFUR
**Strength:** 5; 1; 2; 2; 1; 7 [hp_X]/mL; [hp_Q]/mL; [hp_Q]/mL; [hp_Q]/mL; [hp_Q]/mL; [hp_C]/mL
**Dosage form:** Solution/ Drops
**Route:** Sublingual
**Labeler:** Apex Energetics Inc.
**Marketing category:** UNAPPROVED HOMEOPATHIC
**Pharmacologic class:** Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Non-Standardized Plant Allergenic Extract [EPC], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Plant Proteins [CS], Potassium Compounds [CS], Potassium Salt [EPC], Seed Storage Proteins [CS]
/api/v1/systems/ndc_fda/nodes/63479-0705Hierarchy Explorer
Cross-system equivalences0
No cross-system equivalences mapped for this node.